Boeing Gets an Upgrade, Moderna Wins FDA Vaccine Approval
Stock Movers
00:00
Market Reactions to Moderna's Vaccine Approval and Stock Movements
This chapter explores the fluctuations in Moderna's stock following the FDA's approval of its second generation COVID vaccines, highlighting analysts' mixed responses to the potential impact on sales. It also briefly touches on Bloomberg Radio's offerings and career transition services.
Transcript
Play full episode
